CAD 0.05
(12.5%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2022 | 6.45 Million USD | -8.29% |
2021 | 7.03 Million USD | 8085157.47% |
2020 | -87.00 USD | -100.0% |
2019 | 13.15 Million USD | 85.66% |
2018 | 7.08 Million USD | 1106.81% |
2017 | 587 Thousand USD | -98.76% |
2016 | 47.28 Million USD | 141.15% |
2015 | 19.6 Million USD | -31.27% |
2014 | 28.52 Million USD | 10.23% |
2013 | 25.87 Million USD | 179.94% |
2012 | 9.24 Million USD | 222.24% |
2011 | -7.56 Million USD | -57.45% |
2010 | -4.8 Million USD | -5.69% |
2009 | -4.54 Million USD | 20.16% |
2008 | -5.69 Million USD | -158.23% |
2007 | 9.77 Million USD | -23.5% |
2006 | 12.77 Million USD | 566.67% |
2005 | -2.73 Million USD | 58.85% |
2004 | -6.65 Million USD | -4172.27% |
2003 | -155.72 Thousand USD | 73.3% |
2002 | -583.13 Thousand USD | -97.92% |
2001 | -294.62 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q1 | -3.00 USD | -100.0% |
2023 Q2 | 6.77 Million USD | 225766766.67% |
2023 Q3 | 6.67 Million USD | -1.42% |
2022 FY | 6.45 Million USD | -8.29% |
2022 Q4 | 6.45 Million USD | 5.01% |
2022 Q1 | 6.55 Million USD | -6.75% |
2022 Q2 | 6.43 Million USD | -1.92% |
2022 Q3 | 6.14 Million USD | -4.51% |
2021 FY | 7.03 Million USD | 8085157.47% |
2021 Q4 | 7.03 Million USD | 4.7% |
2021 Q1 | 1.78 Million USD | 0.0% |
2021 Q2 | 4.03 Million USD | 125.43% |
2021 Q3 | 6.71 Million USD | 66.58% |
2020 Q1 | 13.15 Million USD | 2.76% |
2020 FY | -87.00 USD | -100.0% |
2020 Q2 | 11.95 Million USD | -9.14% |
2020 Q3 | 1.63 Million USD | -86.36% |
2019 Q4 | 12.79 Million USD | 1.81% |
2019 Q3 | 12.57 Million USD | 22.79% |
2019 Q2 | 10.23 Million USD | 44.52% |
2019 FY | 13.15 Million USD | 85.66% |
2019 Q1 | 7.08 Million USD | -11.44% |
2018 Q4 | 7.99 Million USD | -37.65% |
2018 FY | 7.08 Million USD | 1106.81% |
2018 Q3 | 12.82 Million USD | -43.92% |
2018 Q2 | 22.87 Million USD | 3797.44% |
2018 Q1 | 587 Thousand USD | 213.76% |
2017 Q3 | 52.6 Million USD | -3.27% |
2017 Q2 | 54.38 Million USD | 15.02% |
2017 Q1 | 47.28 Million USD | 5.63% |
2017 FY | 587 Thousand USD | -98.76% |
2017 Q4 | -516 Thousand USD | -100.98% |
2016 Q2 | 22.94 Million USD | 17.04% |
2016 FY | 47.28 Million USD | 141.15% |
2016 Q4 | 44.76 Million USD | 30.65% |
2016 Q1 | 19.6 Million USD | 69.77% |
2016 Q3 | 34.26 Million USD | 49.3% |
2015 Q1 | 28.52 Million USD | 17.63% |
2015 Q4 | 11.54 Million USD | 937.65% |
2015 FY | 19.6 Million USD | -31.27% |
2015 Q3 | 1.11 Million USD | 120.47% |
2015 Q2 | -5.43 Million USD | -119.06% |
2014 Q4 | 24.25 Million USD | 7.15% |
2014 Q3 | 22.63 Million USD | -15.25% |
2014 Q2 | 26.7 Million USD | 3.2% |
2014 Q1 | 25.87 Million USD | 3.03% |
2014 FY | 28.52 Million USD | 10.23% |
2013 Q2 | 23.69 Million USD | 156.32% |
2013 FY | 25.87 Million USD | 179.94% |
2013 Q4 | 25.11 Million USD | 0.28% |
2013 Q3 | 25.04 Million USD | 5.71% |
2013 Q1 | 9.24 Million USD | 41.8% |
2012 Q3 | 1.04 Million USD | 171.91% |
2012 Q1 | -7.56 Million USD | 41.6% |
2012 Q2 | -1.44 Million USD | 80.84% |
2012 FY | 9.24 Million USD | 222.24% |
2012 Q4 | 6.51 Million USD | 525.62% |
2011 FY | -7.56 Million USD | -57.45% |
2011 Q4 | -12.94 Million USD | -332.03% |
2011 Q1 | -4.8 Million USD | 37.11% |
2011 Q2 | -7.4 Million USD | -54.1% |
2011 Q3 | -2.99 Million USD | 59.51% |
2010 Q3 | -11.37 Million USD | 25.15% |
2010 FY | -4.8 Million USD | -5.69% |
2010 Q1 | -4.54 Million USD | 42.97% |
2010 Q4 | -7.63 Million USD | 32.85% |
2010 Q2 | -15.19 Million USD | -234.37% |
2009 Q4 | -7.96 Million USD | -700.4% |
2009 Q2 | -2.47 Million USD | 56.47% |
2009 FY | -4.54 Million USD | 20.16% |
2009 Q1 | -5.69 Million USD | -240.78% |
2009 Q3 | 1.32 Million USD | 153.57% |
2008 FY | -5.69 Million USD | -158.23% |
2008 Q1 | 9.77 Million USD | -14.51% |
2008 Q2 | 8.9 Million USD | -8.86% |
2008 Q3 | 4.21 Million USD | -52.68% |
2008 Q4 | 4.04 Million USD | -4.08% |
2007 Q3 | 10.93 Million USD | -30.61% |
2007 Q4 | 11.43 Million USD | 4.51% |
2007 Q2 | 15.76 Million USD | 23.39% |
2007 Q1 | 12.77 Million USD | -8.35% |
2007 FY | 9.77 Million USD | -23.5% |
2006 Q1 | -2.73 Million USD | -25.1% |
2006 FY | 12.77 Million USD | 566.67% |
2006 Q4 | 13.93 Million USD | 15763.16% |
2006 Q2 | -1.27 Million USD | 53.52% |
2006 Q3 | -88.99 Thousand USD | 93.01% |
2005 Q4 | -2.18 Million USD | 65.37% |
2005 FY | -2.73 Million USD | 58.85% |
2005 Q1 | -6.65 Million USD | -0.32% |
2005 Q2 | -6.3 Million USD | 5.16% |
2005 Q3 | -6.31 Million USD | -0.15% |
2004 Q3 | -345.35 Thousand USD | -58.42% |
2004 Q4 | -6.63 Million USD | -1820.23% |
2004 Q2 | -217.99 Thousand USD | -39.99% |
2004 Q1 | -155.72 Thousand USD | 89.69% |
2004 FY | -6.65 Million USD | -4172.27% |
2003 Q2 | -351.26 Thousand USD | 39.76% |
2003 Q1 | -583.13 Thousand USD | 39.82% |
2003 Q3 | -217 Thousand USD | 38.22% |
2003 Q4 | -1.5 Million USD | -595.73% |
2003 FY | -155.72 Thousand USD | 73.3% |
2002 Q2 | -239.89 Thousand USD | 12.25% |
2002 Q3 | -238.55 Thousand USD | 0.56% |
2002 FY | -583.13 Thousand USD | -97.92% |
2002 Q4 | -968.92 Thousand USD | -306.17% |
2002 Q1 | -273.37 Thousand USD | 0.0% |
2001 FY | -294.62 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Appili Therapeutics Inc. | 8.09 Million CAD | 20.263% |
Eupraxia Pharmaceuticals Inc. | -11.72 Million CAD | 155.033% |
Helix BioPharma Corp. | -1.08 Million CAD | 696.762% |
Microbix Biosystems Inc. | -4.96 Million CAD | 230.03% |
Medicenna Therapeutics Corp. | -16.98 Million CAD | 137.987% |
Satellos Bioscience Inc. | -22.06 Million CAD | 129.234% |
Oncolytics Biotech Inc. | -31.11 Million CAD | 120.735% |
Sernova Corp. | -8.58 Million CAD | 175.136% |